Literature DB >> 23180443

Central pontine and extrapontine myelinolysis secondary to fast correction of severe hyponatremia and hypokalemia in an alcoholic patient.

Ahmad Ghaith Tarakji1, Ahmad Raed Tarakji, Uzma Shaheen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180443     DOI: 10.1007/s11255-012-0329-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  8 in total

1.  Outcome of central pontine and extrapontine myelinolysis (n = 44).

Authors:  H Menger; J Jörg
Journal:  J Neurol       Date:  1999-08       Impact factor: 4.849

2.  Central pontine myelinolysis temporally related to hypophosphataemia.

Authors:  A W Michell; D J Burn; P J Reading
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

Review 3.  Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes.

Authors:  R J Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

4.  A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion.

Authors:  Tomas Berl; Asghar Rastegar
Journal:  Am J Kidney Dis       Date:  2010-04       Impact factor: 8.860

5.  Osmotic demyelination syndrome.

Authors:  Rachel Abbott; Eli Silber; Joerg Felber; Enefiok Ekpo
Journal:  BMJ       Date:  2005-10-08

Review 6.  Central pontine myelinolysis.

Authors:  Christian Lampl; Kambiz Yazdi
Journal:  Eur Neurol       Date:  2002       Impact factor: 1.710

7.  Overcorrection of hyponatremia is a medical emergency.

Authors:  Richard H Sterns; John K Hix
Journal:  Kidney Int       Date:  2009-09       Impact factor: 10.612

8.  Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats.

Authors:  Fabrice Gankam Kengne; Alain Soupart; Roland Pochet; Jean-Pierre Brion; Guy Decaux
Journal:  Kidney Int       Date:  2009-07-15       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.